Overview (04 Nov 2026)
Lyka Labs Ltd
LYKALABS
INE933A01014

Pharmaceuticals
Result was last declared on 01 Aug 2025
0

Prev. Close
Previous Close
75.57
Current Close
75.57
Current High
75.57
Current Low
74.06
52 Week High
96.68
52 Week Low
44.49
Resistance 1
76.08
Resistance 2
76.58
Support 1
74.57
Support 2
73.06
Std Deviation
6.39%
DMA 200
68.17
DMA 50
79.41
DMA 20
78.41
Fundamentals and Ratios
Standalone
Trailing EPS
0
Forwad EPS
-10.08
Trailing P/E
NA
Forward P/E
NA
PEG Ratio
0.65
Mkt. Cap (Cr)
Market Cap (Cr)
269.71
Total Debt(Cr)
Tot. Debt(Cr)
44.31
Reserve (Cr)
59.59
Book Value
26.09
P/BV Ratio
2.9
ROCE(%)
-16.00
ROE
-24.00
Consolidated
Trailing EPS
0
Forwad EPS
-1.6
Trailing P/E
0.89
Forward P/E
-47.23
PEG Ratio
1.19
Mkt. Cap (Cr)
Market Cap (Cr)
269.71
Total Debt(Cr)
Tot. Debt(Cr)
44.31
Reserve (Cr)
59.59
Book Value
26.82
P/BV Ratio
2.82
ROCE(%)
-1.44
ROE
-5.1200

 

Financial Result
Standalone
TypeSep-26Jun-26Mar-26Dec-25Sep-25FY25-26
Revenue44.242.3128.0330.7332.97120.91
Other Income0.590.420.511.261.223.97
Total Income44.7942.7328.5431.9934.19124.88
Interest1.021.010.870.820.793.33
Expenditure-43.67-40.73-35.43-31.71-38.98-135.10
PBDT0.000.000.000.000.000.00
Depreciation-2.05-2.01-2.04-2.08-2.07-8.46
PBT1.121.99-29.900.28-4.80-33.24
Tax0.200.110.130.001.170.95
Equity36.1536.1535.690.000.0035.69
OPM2.504.66-104.770.90-14.55-26.61
Net Profit1.322.1-29.770.28-3.63-32.29
NPM2.954.91-104.310.91-11-25.86
EPS0.360.58-8.50.08-1.020
Consolidated
TypeSep-26Jun-26Mar-26Dec-25Sep-25FY25-26
Revenue44.242.3128.0330.7336.66128.445
Other Income0.620.420.611.161.093.50
Total Income44.8242.7328.6431.8937.75131.94
Interest1.021.010.700.820.793.33
Expenditure-43.75-40.78-37.23-32.05-42.14-143.72
PBDT0.000.000.000.000.000.00
Depreciation-2.05-2.01-2.04-2.16-2.15-8.46
PBT1.071.95-8.590.000.00-11.78
Tax0.200.100.520.011.171.34
Equity36.1536.1535.690.000.0035.69
OPM2.394.56-29.990.000.00-8.93
Net Profit1.272.05-8.07-0.15-3.21-10.44
NPM2.834.8-28.18-0.47-8.51-7.91
EPS0.360.57-2.130-0.940
Annual Reports

Corporate Action
Quarterly Result
Dividend
Bonus
Split

Mutual Fund Holddings